News · 26 weeks82-36%
2025-12-142026-06-07
Mix6190d
- Insider42(69%)
- SEC Filings8(13%)
- Other6(10%)
- Analyst3(5%)
- Earnings2(3%)
Latest news
25 items- SECSolventum Corporation filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - Solventum Corp (0001964738) (Filer)
- SECSEC Form SD filed by Solventum CorporationSD - Solventum Corp (0001964738) (Filer)
- SECSolventum Corporation filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - Solventum Corp (0001964738) (Filer)
- PRSolventum to Participate in the 2026 Jefferies Healthcare ConferenceEAGAN, Minn., May 27, 2026 /PRNewswire/ -- Solventum (NYSE:SOLV) announced today that management will participate in a fireside chat at the Jefferies Healthcare Conference on Wednesday, Jun. 3, 2026, beginning at approximately 9:55 a.m. EDT in New York, NY. A live and archived replay of the fireside chat will be available on the company's website at investors.solventum.com.About SolventumAt Solventum, we enable better, smarter, safer healthcare to improve lives. As a new company with a long legacy of creating breakthrough solutions for our customers' toughest challenges, we pion
- SECSolventum Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - Solventum Corp (0001964738) (Filer)
- INSIDERSEC Form 4 filed by Director Alban Carlos4 - Solventum Corp (0001964738) (Issuer)
- INSIDERSEC Form 4 filed by Director Cox Carrie Smith4 - Solventum Corp (0001964738) (Issuer)
- INSIDERSEC Form 4 filed by Director Devore Susan D.4 - Solventum Corp (0001964738) (Issuer)
- INSIDERSEC Form 4 filed by Director Edwards Shirley Ann4 - Solventum Corp (0001964738) (Issuer)
- INSIDERSEC Form 4 filed by Director Eisenberg Glenn A4 - Solventum Corp (0001964738) (Issuer)
- INSIDERSEC Form 4 filed by Director Harris Bernard A Jr4 - Solventum Corp (0001964738) (Issuer)
- INSIDERSEC Form 4 filed by Director May Karen J4 - Solventum Corp (0001964738) (Issuer)
- INSIDERSEC Form 4 filed by Director Mily Elizabeth4 - Solventum Corp (0001964738) (Issuer)
- INSIDERSEC Form 4 filed by Director Weiland John H4 - Solventum Corp (0001964738) (Issuer)
- INSIDERSEC Form 4 filed by Director Wendell Amy Mcbride4 - Solventum Corp (0001964738) (Issuer)
- INSIDERSEC Form 4 filed by Director Wilson Darryl L.4 - Solventum Corp (0001964738) (Issuer)
- INSIDERChief Human Resources Officer Gomez Tammy L converted options into 3,960 shares and covered exercise/tax liability with 1,668 shares, increasing direct ownership by 21% to 13,362 units (SEC Form 4)4 - Solventum Corp (0001964738) (Issuer)
- INSIDERChief Financial Officer Mcmillan Wayde D. converted options into 9,503 shares and covered exercise/tax liability with 4,404 shares, increasing direct ownership by 12% to 48,637 units (SEC Form 4)4 - Solventum Corp (0001964738) (Issuer)
- INSIDERChief Supply Chain Officer Harrington Paul S covered exercise/tax liability with 1,678 shares and converted options into 3,960 shares, increasing direct ownership by 13% to 20,452 units (SEC Form 4)4 - Solventum Corp (0001964738) (Issuer)
- INSIDERChief Accounting Officer Wilcox Mary T converted options into 2,376 shares and covered exercise/tax liability with 728 shares, increasing direct ownership by 31% to 6,904 units (SEC Form 4)4 - Solventum Corp (0001964738) (Issuer)
- INSIDERSEC Form 4 filed by Solventum Corporation4 - Solventum Corp (0001964738) (Issuer)
- INSIDERChief Executive Officer Hanson Bryan C converted options into 34,315 shares and covered exercise/tax liability with 13,503 shares, increasing direct ownership by 17% to 144,722 units (SEC Form 4)4 - Solventum Corp (0001964738) (Issuer)
- INSIDERChief Information Officer Landucci Amy converted options into 4,422 shares and covered exercise/tax liability with 2,017 shares, increasing direct ownership by 6% to 39,888 units (SEC Form 4)4 - Solventum Corp (0001964738) (Issuer)
- ANALYSTWedbush initiated coverage on Solventum with a new price targetWedbush initiated coverage of Solventum with a rating of Outperform and set a new price target of $94.00
- ANALYSTSolventum downgraded by UBS with a new price targetUBS downgraded Solventum from Buy to Neutral and set a new price target of $50.00
SOLV FAQ
6 questionsWhere does SOLV stock trade?
Solventum Corporation (SOLV) is listed on NYSE.What sector and industry is SOLV in?
Solventum Corporation operates in the Health Care sector, Medical/Dental Instruments industry.When did Solventum Corporation go public?
Solventum Corporation (SOLV) completed its IPO in 2024.What are analysts saying about SOLV?
Solventum Corporation has had 8 recent analyst actions on file. The most recent action was from Wedbush: Outperform on 2026-05-15.What companies are similar to SOLV?
Notable peers in the same industry include SYK (Stryker Corporation), MMM (3M Company), BSX (Boston Scientific Corporation), MDLN (Medline Inc.), BDX (Becton Dickinson and Company). Compare SOLV side-by-side with any of them on Quantisnow.How can I track SOLV on Quantisnow?
Quantisnow aggregates Solventum Corporation's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow SOLV to receive live email and push alerts on every new disclosure.